- Uppsala, Sweden-based Orexo developed a low dose version of its opioid dependence treatment Zubsolv.
- The Mi-eye 2 is a second-generation diagnostic device used to diagnose and treat joint injuries.
- BurstDR is a physician-developed form of spinal cord stimulation used to treat patients with chronic pain.
- Jerusalem-based Teva Pharmaceutical Industries developed abacavir and lamivudine tablets to treat adults with HIV-1 infection.
More articles on supply chain:
FedEx to open new Ohio distribution center in 2017
Insmed buys AstraZeneca’s respiratory drug for $150M: 5 things to know
Novartis restructures research unit, sheds 175 jobs: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
